Volume 41 · Number 5
MAY 2011
The Concept of Schizophrenia: From the 1850s to the DSM-5
Psychiatr Ann. 2011 May;41(5):289-295
By Dawn Bruijnzeel, MD; Rajiv Tandon, MD
Dementia praecox or schizophrenia has been considered a unique disease entity for the past century. At the beginning of the 20th century, Kraepelin combined dementia paranoides, hebephrenia, and catatonia into a single dementia praecox, which he distinguished from manic-depressive insanity. Soon thereafter, Eugen Bleuler substantially broadened the boundaries of this entity, which he renamed the “schizophrenias.”
ABOUT THE AUTHORS
Dawn Bruijnzeel, MD, is Assistant Professor of Psychiatry; and Rajiv Tandon, MD, is Professor of Psychiatry, University of Florida, Gainesville, FL.
Address correspondence to Rajiv Tandon, MD, Professor of Psychiatry, University of Florida, PO Box 103424, Gainesville, FL 32610-3424; or email: [email protected].
This article was independently developed by Dr. Bruijnzeel and Dr. Tandon. Dr. Tandon is a member of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, (DSM-5) workgroup on Schizophrenia and Related Disorders and the World Psychiatry Association Section on Pharmacopsychiatry. The opinions expressed in the article are those of the authors alone and do not purport to represent any of the organizations to which the authors belong.
Dr. Bruijnzeel and Dr. Tandon have disclosed no relevant financial relationships.
Treatment Challenges of Schizophrenia
Another Spring — Renewal in the Face of September
Jan Fawcett, MD
Treatment Challenges of Schizophrenia
Philip G. Janicak, MD
In This Issue: Treatment Challenges of Schizophrenia
A 7-year-Old Boy with ADHD
Bliss A. Chalemian, MD;
Asad Amir, MD;
Sree Latha Krishna Jadapalle, MD
A 68-Year-Old Woman with Lung Cancer and Late-Onset Bipolar Disorder
Johanna W. DeKay, MD;
Jeremy Matuszak, MD
Management of Negative Symptoms in Schizophrenia
Jeffrey Rado, MD;
Jeffrey T. Rado, MD
Long-Acting Injectable Antipsychotics and the Management of Nonadherence
Peter J. Weiden, MD;
Hugo Solari, MD;
Shiyun Kim, PharmD;
Jeffrey R. Bishop, PharmD
The Adherence Interview: Better Information, Better Alliance
Peter J. Weiden, MD
The Concept of Schizophrenia: From the 1850s to the DSM-5
Dawn Bruijnzeel, MD;
Rajiv Tandon, MD
